Mayo Clinic reports that semaglutide medications, like Wegovy , do begin to work on appetite control relatively soon after use as quickly as the first week
Clinical studies, including the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trials, have shown that participants experienced an average weight loss of about 15% over 68 weeks
Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review
[13] This warning is based on rodent studies
A : If your doctor decides GLP-1 treatment isnt suitable for you, your consultation will not be charged, and any payment made will be fully refunded
Both the Wegovy pill and shot deliver similar results in terms of weight loss, but the time it takes to see results may vary slightly due to the differences in administration